This study presents comprehensive morphological and mechanical properties (static, dynamic) of open-cell rigid foams (Pacific Research Laboratories Inc. Vashon, WA) and a synthetic vertebral body derived from each of the foams. Synthetic vertebrae were comprised of a cylindrical open-cell foam core enclosed by a fiberglass resin cortex. The open-cell rigid foam was shown to have similar morphology and porosity as human vertebral cancellous bone, and exhibited a crush or fracture consolidation band typical of open-celled materials and cancellous bone. However, the foam material density was 40% lower than natural cancellous bone resulting in a lower compressive apparent strength and apparent modulus in comparison to human bone. During cyclic, mean compression fatigue tests, the synthetic vertebrae exhibited an initial apparent modulus, progressive modulus reduction, strain accumulation and S-N curve behaviour similar to human and animal vertebral cancellous bone. Synthetic open-cell foam vertebrae offer researchers an alternative to human vertebral bone for static and dynamic biomechanical experiments, including studies examining the effects of cement injection.

Previously reported antibiotic-impregnated cement strengths have been based on uniaxial and fatigue testing methodologies. These methods may not provide an accurate characterization of bone cement's true load-bearing capacity in total joint replacement (TJR). The present study utilized biaxial testing to report on the properties of antibiotic-impregnated cement. Test groups included: PMMA mixed with Vancomycin, Gentamicin, Tobramycin, or no antibiotic (control). In comparison to the control group, PMMA samples mixed with powdered gentamicin resulted in an increase in the mean elastic modulus by 6.50% versus a drop noted with powdered vancomycin and tobramycin by 2.65 and 1.37% respectively. The mean elastic modulus in samples containing liquid gentamicin dropped by 11.6%. This study supports the continued use of powdered antibiotics when clinically indicated, but suggest caution in the use of liquid gentamicin in TJR.

No abstract

No abstract

No abstract